The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase

References

• WHO: COPD: Burden. World health organization. [Cited 2020 Mar 5]. Available from: http://www.who.int/respiratory/copd/burden/en/index.html
   Google Scholar
• National Center for Health Statistics: National Health Interview Survey, 1982–1996, 1997–2002. Information cited in: American lung association, epidemiology and statistics unit. Trends in Chronic Bronchitis and Emphysema: Morbidity and Mortality; 2004.
   Google Scholar
• Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol. 2006;100(5–6):481–499.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD (GOLD 2018). [Cited 2020 Mar 5]. Available from: http://www.goldcopd.org
   Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American college of physicians, American college of chest physicians, American thoracic society, and European respiratory society. Ann Int Med. 2011;155(3):179–191.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. In: surveillance summaries. 2002. August 2, 2002. MMWR Surveill Summ, 51(No. SS-6). 1–16.
   Google Scholar
• Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National health and nutrition examination survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654.
   PubMed Web of Science ®Google Scholar
• Brooks SM. Surveillance for respiratory hazards. ATS News. 1982;8(12–6).
   Google Scholar
• Gupta N, Pinto LM, Morogan A, et al. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873–884.
   PubMed Web of Science ®Google Scholar
• Pasquale MK, Xu Y, Baker CL, et al. COPD exacerbations associated with the modified medical research council scale and COPD assessment test among humana medicare members. Int J Chron Obstruct Pulmon Dis. 2016;11:111–121.
   PubMed Web of Science ®Google Scholar
• Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Lu C, Li H. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540.
   PubMed Web of Science ®Google Scholar
• Santus P, Centanni S, Verga M, et al. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. Respir Med. 2006;100:1277–1281.
   PubMed Web of Science ®Google Scholar
• Santus P, Radovanovic D, Henchi S, et al. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients. Respir Physiol Neurobiol. 2014;197:36–45.
   PubMed Web of Science ®Google Scholar
• Casaburi R, Maltais F, Porszasz J, et al. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(9):1351–1361.
   PubMedGoogle Scholar
• Luis López-Campos J, Fernández-Villar A, Represas Represas C, et al. Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort. Eur Clin Respir J. 2017;4(1):1394132.
   PubMedGoogle Scholar
• Von Elm E, Altman DG, Egger M, et al. STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
   PubMed Web of Science ®Google Scholar
• Tsiligianni IG, van der Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12:20.
   PubMed Web of Science ®Google Scholar
• Dal Negro RW, Bonadiman L, Turco P. Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study. Multidiscip Resp Med. 2014;9(1):15.
   PubMedGoogle Scholar
• Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Dalal AA, Becker PT, et al. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity. Int J Chron Obstruct Pulmon Dis. 2015;10:1477–1486.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968.
   PubMed Web of Science ®Google Scholar
• Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111–124.
   PubMedGoogle Scholar
• Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.
   PubMed Web of Science ®Google Scholar
• Papaioannou M, Pitsiou G, Manika K, et al. COPD assessment test: a simple tool to evaluate disease severity and response to treatment. COPD. 2014;11(5):489–495.
   PubMedGoogle Scholar
• Jones PW. COPD assessment test- rationale, development, validation and performance. COPD. 2013;10(2):269–271.
   PubMedGoogle Scholar
• Pothirat C, Chaiwong W, Limsukon A, et al. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score. Int J Chron Obstruct Pulmon Dis. 2015;10:277–282.
   PubMed Web of Science ®Google Scholar
• Contoli M, Rogliani P, Di Marco F, et al. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study. Ther Adv Respir Dis. 2019;13:1753466619888128.
   Web of Science ®Google Scholar
• Ghobadi H, Ahari SS, Kameli A, et al. The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients. Tanaffos. 2012;1(2):22–26.
   Google Scholar
• Kelly JL, Bamsey O, Smith C, et al. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration. 2012;84(3):193–199.
   PubMed Web of Science ®Google Scholar
• Park J, Lee CH, Lee YJ, et al. Longitudinal changes in lung hyperinflation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:501–508.
   PubMed Web of Science ®Google Scholar
• Rossi A, Aisanov Z, Avdeev S, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109(7):785–802.
   PubMed Web of Science ®Google Scholar
• Felipe C, Bartolome C, Miguel D, et al. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group. Chest. 2015;148(4):986–994.
   PubMed Web of Science ®Google Scholar
• Capozzolo A, Carratù P, Dragonieri S, et al. Clinical and functional lung parameters associated with frequent exacerbator phenotype in subjects with severe COPD. Respir Care. 2017;62(5):572–578.
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic air flow obstruction. Br Med J. 1977;1(6077):1645–1648.
   PubMed Web of Science ®Google Scholar
• Casanova C, de Torres JP, Aguirre-Jaime A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011;184(9):1015–1021.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192.
   PubMed Web of Science ®Google Scholar
• Teculescu DB, Bohadana AB, Peslin R, et al. Variability, reproducibility and observer difference of body plethysmographic measurements. Clin Physiol.. 1982;2(2):127–138.
   PubMedGoogle Scholar
• Bourbeau J, Maltais F, Rouleau M, et al. French-Canadian version of the chronic respiratory and st george’s respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J. 2004;11(7):480–486.
   PubMedGoogle Scholar